Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

KTRA Kintara Therapeutics Inc

0,2109

-0,0459 (-17,87%)

08 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Kintara Therapeutics Charts.

Kintara Therapeutics (NASDAQ:KTRA)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Kintara Therapeutics Charts.

News Kintara Therapeutics Inc

Form 425 - Prospectuses and communications, business combinations
Montag 3 Juni 2024 (5 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 3 Juni 2024 (5 Tage vor) • Edgar (US Regulatory)

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)
Montag 3 Juni 2024 (5 Tage vor) • PR Newswire (US)

Form ARS - Annual Report to Security Holders
Freitag 17 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 17 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
Dienstag 14 Mai 2024 (3 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form S-4 - Registration of securities, business combinations
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm
Freitag 5 April 2024 (2 Monate vor) • PR Newswire (US)

Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Mittwoch 3 April 2024 (2 Monate vor) • PR Newswire (US)

Weitere Kintara Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen